This week, which stocks lagged or dragged? Weekly Winners column keeps up with market trends, helping Tigers sort out the week's hottest sectors, stock winners and important news.

Below are top 10 stock gainers with market cap above $1 billion for the week ended Jan. 10:

FuboTV Soars 255% as Disney Nears Deal to Merge Hulu + Live into Fubo

Walt Disney and streaming provider fuboTV Inc., are nearing a deal to combine their online live TV businesses, according to people familiar with the matter. 

As part of the transaction, Disney will fold its Hulu + Live TV business into Fubo, creating a new venture that will be 70% owned by Disney and the rest by Fubo, the people said, asking not to be identified discussing confidential information.

Vir Biotechnology Reports Positive Phase 2 Results, Shares Surge by 61%

Following the publication of encouraging results from Phase 2 studies for two investigational cancer treatments, Vir Biotechnology (VIR) saw a notable 61% increase in its stock price this week, thereby emphasizing developments in its oncology pipeline.

Regarding its continuing Phase 2 studies for the experimental drugs VIR-5818 and VIR-5500, Vir Biotechnology reported hopeful developments. Targeting focused effects inside tumor microenvironment to reduce side effects in healthy tissues, the medicines make use of Sanofi's patented PRO-XTEN masking technology.

Constellation Energy Stock Jumps 21% as Calpine Buy Becomes a Reality

Constellation Energy Corp stock soared 21% this week after the company reached an agreement to buy Calpine, a move that creates the nation’s largest clean energy provider with a broader array of products.

The net purchase price of the deal is roughly $26.6 billion, which includes the assumption of debt for the privately held Calpine, and values Calpine at a multiple of 7.9 times its 2026 enterprise value to Ebitda or earnings before interest, taxes, depreciation, and amortization.

Walgreens Stock Pops 24% After a Strong Quarter

Shares of Walgreens Boots Alliance were trading sharply higher after the retail pharmacy chain reported strong quarterly earnings.

For its fiscal first quarter ended Nov. 30, Walgreens reported adjusted earnings of 51 cents a share, beating Wall Street's call for 38 cents, according to FactSet. Sales of $39.5 billion topped the consensus estimate of $37.4 billion and grew 7.5% from the year-ago quarter, "reflecting sales growth across all business segments."